The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[3H](4-(((4-(2-(((R,E)-4-((R)-1-(7-ethoxy-7-oxoheptyl)-5-oxopyrrolidin-2-yl)-1,1-difluoro-1-phenylbut-3-en-2-yl)oxy)-2-oxoethyl)phenoxy)carbonyl)amino)-1-hydroxybutane-1,1-diyl)diphosphonic acid triethylamine salt ID: ALA2092899
PubChem CID: 70689210
Max Phase: Preclinical
Molecular Formula: C42H63F2N3O14P2
Molecular Weight: 832.72
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)CC.[3H]C([3H])([3H])COC(=O)CCCCCCN1C(=O)CC[C@@H]1/C=C/[C@@H](OC(=O)Cc1ccc(OC(=O)NCCCC(O)(P(=O)(O)O)P(=O)(O)O)cc1)C(F)(F)c1ccccc1
Standard InChI: InChI=1S/C36H48F2N2O14P2.C6H15N/c1-2-52-32(42)13-8-3-4-9-24-40-28(17-21-31(40)41)16-20-30(36(37,38)27-11-6-5-7-12-27)54-33(43)25-26-14-18-29(19-15-26)53-34(44)39-23-10-22-35(45,55(46,47)48)56(49,50)51;1-4-7(5-2)6-3/h5-7,11-12,14-16,18-20,28,30,45H,2-4,8-10,13,17,21-25H2,1H3,(H,39,44)(H2,46,47,48)(H2,49,50,51);4-6H2,1-3H3/b20-16+;/t28-,30+;/m0./s1/i1T3;
Standard InChI Key: VDTQPNRDKPWCPT-STOLSZDDSA-N
Molfile:
RDKit 2D
66 67 0 0 0 0 0 0 0 0999 V2000
5.9023 -19.9955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6167 -19.5830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1878 -19.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6167 -18.7581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3311 -18.3456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3311 -19.9955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0456 -19.5830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3792 -15.4917 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.7958 -16.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2082 -15.4892 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.9792 -15.3917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6936 -14.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2025 -15.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6881 -15.7452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1427 -16.4338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9381 -16.2141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9831 -14.3049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6533 -16.6255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3671 -16.2118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0822 -16.6232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0835 -17.4482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5111 -16.6209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5110 -17.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2253 -17.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9401 -17.4445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9361 -16.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2213 -16.2077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6936 -14.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4081 -13.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1226 -14.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8371 -13.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5515 -14.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2660 -13.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9805 -14.1542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2660 -12.9167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6949 -13.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4094 -14.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3697 -17.8618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3710 -18.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6546 -17.4504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6572 -19.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9424 -18.6873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2291 -19.1003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2300 -19.9262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9501 -20.3373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6605 -19.9220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5167 -20.3408 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1990 -19.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9122 -20.3450 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2014 -19.1054 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6279 -19.9346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6303 -19.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3460 -18.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3484 -17.8742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0641 -17.4638 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
-1.6352 -17.4596 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
-2.3542 -17.0458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9195 -17.8700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6376 -16.6346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9250 -17.0417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0665 -16.6388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7774 -17.8784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7833 -17.0500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1239 -13.7417 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
8.4094 -14.9792 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
9.1239 -14.5667 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 3 1 0
1 2 1 0
2 4 1 0
2 6 1 0
4 5 1 0
6 7 1 0
11 12 1 0
33 35 2 0
20 21 1 6
34 36 1 0
13 14 1 0
36 37 1 0
9 22 1 0
21 38 1 0
14 15 1 0
38 39 1 0
22 23 2 0
38 40 2 0
15 16 1 0
39 41 1 0
23 24 1 0
41 42 2 0
16 11 1 0
42 43 1 0
24 25 2 0
43 44 2 0
11 13 1 0
44 45 1 0
25 26 1 0
45 46 2 0
46 41 1 0
13 17 2 0
44 47 1 0
26 27 2 0
47 48 1 0
27 22 1 0
48 49 1 0
10 9 1 0
48 50 2 0
12 28 1 0
49 51 1 0
16 18 1 1
51 52 1 0
28 29 1 0
52 53 1 0
53 54 1 0
29 30 1 0
54 55 1 0
18 19 2 0
54 56 1 0
30 31 1 0
54 57 1 0
9 8 1 0
56 58 1 0
31 32 1 0
56 59 1 0
19 20 1 0
56 60 2 0
32 33 1 0
55 61 1 0
20 9 1 0
55 62 1 0
33 34 1 0
55 63 2 0
37 64 1 0
37 65 1 0
37 66 1 0
M ISO 3 64 3 65 3 66 3
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 832.72Molecular Weight (Monoisotopic): 832.2549AlogP: 4.86#Rotatable Bonds: 22Polar Surface Area: 246.53Molecular Species: ACIDHBA: 10HBD: 6#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 0.69CX Basic pKa: ┄CX LogP: 3.39CX LogD: -1.54Aromatic Rings: 2Heavy Atoms: 56QED Weighted: 0.04Np Likeness Score: -0.11
References 1. Arns S, Gibe R, Moreau A, Monzur Morshed M, Young RN.. (2012) Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis., 20 (6): [PMID:22341574 ] [10.1016/j.bmc.2012.01.024 ]